MedPath

Evaluating Occupational Stress in Surgeons and Musicians: A Multi-modal Pilot Study Using Wearable EEG, Biomarker Analysis and Validated Questionnaires

Recruiting
Conditions
Occupational Stress
Registration Number
NCT06875882
Lead Sponsor
M.D. Anderson Cancer Center
Brief Summary

To learn about occupational stress among surgeons and musicians by integrating psychological assessments, neurophysiological measures, and biomarkers.

Detailed Description

Primary Objectives • To assess the change in occupational stress among surgeons and musicians by measuring physiological and psychological stress markers.

Endpoints:

* Changes in salivary cortisol levels (before and after surgeries for surgeons and live public performances for musicians).

* Changes in State-Trait Anxiety Inventory-Short (STAI-S) scores (administered pre- and post-surgery/performance).

SECONDARY OBJECTIVES AND ENDPOINTS

• Assessing and comparing anxiety and burnout, based on the MBI, STAI-T, M-PAS, and SCAT, in surgeons and musicians

Endpoints:

* Baseline levels of anxiety and burnout measured using the MBI, M-PAS, STAI-T, and SCAT.

* Emotional exhaustion, depersonalization, and personal accomplishment from the MBI in both groups.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Adults aged 18 years and older
  • Professional musicians (i.e., those with academic or orchestral appointments) or MD Anderson Neurosurgeons
  • For Musicians only: You will have a musical performance within three months of study enrollment.

For Neurosurgeons only: You will perform a surgical procedure within three months of study enrollment.

Exclusion Criteria
  • Individuals who are unable to provide informed consent
  • Individuals diagnosed with severe cognitive impairments, severe psychiatric disorders, or hearing or visual impairments that could affect participation
  • Individuals previously enrolled in the study
  • Non-English-speaking musicians and/or surgeons

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety and Adverse Events (AEs).Through study completion; an average of 1 year.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MD Anderson Cancer Center

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath